Evidence-based insertion and maintenance strategies for neonatal vascular access devices (VAD) exist to reduce the causes of VAD failure and complications in neonates. Peripheral intravenous catheter failure and complications including, infiltration, extravasation, phlebitis, dislodgement with/without removal, and infection are majorly influenced by catheter securement methods.
The study is a retrospective, observational study using routinely collected data on intravenous device use in a large neonatal intensive care unit in Qatar.
A 6-month historical cohort was compared with a 6-month cohort after the introduction of an octyl-butyl-cyanoacrylate glue (CG).
They concluded that the risk of developing device-related phlebitis and premature device removal, increased significantly if CG was not used for adjunct catheter securement. In parallel with the currently published literature, this study’s findings support the use of CG for vascular device securement. When device securement and stabilization concerns are most pertinent CG is a safe and effective adjunct to reducing therapy failures in the neonatal patient population.

Authors : Matheus Fpt van Rens1, Timothy R Spencer2, Kevin Hugill3, Airene Lv Francia1, Fredericus Hj van Loon45, Mohammad Aa Bayoumi1

1. Women’s Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar.
2. Global Vascular Access LLC, Scottsdale, AZ, USA.
3. Department of Nursing and Midwifery Education, Hamad Medical Corporation, Doha, Qatar.
4. Anesthesiology, Intensive Care and Pain Medicine, Catharina Hospital, Eindhoven, The Netherlands.
5. PeriOperative Care & Technology, Fontys University of Applied Sciences, Eindhoven, The Netherlands.


To consult the study

To see the presentation during the 5th GAVePed congress in Rimini, follow this link